Relistor, Injektionslösung

7680586520029 CH-58652 Injektionslösung
Relistor, Injektionslösung
Relistor, Injektionslösung
Relistor, Injektionslösung
1 / 3
google

Article details

Package size
7
Selling units
7
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
03/03/2025
Summary of Product Characteristics
Français
03/03/2025
Summary of Product Characteristics
Italien
03/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
12.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
4.14 MG Substance HBESI

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
58652
Drug name
Relistor, Injektionslösung
Galenic form
LSPA
ATC Code
A06AH01
Authorization status
Z
Dispensing category
B
First authorization
15/04/2009
Authorization expiration date
31/12/9999
IT Number
04.99.0.
Domain
Human medicine
Field of application
Opiat-induzierte Obstipation

Package details

Description (FR)
RELISTOR sol inj 12 mg/0.6ml flac 7 pce
Description (DE)
RELISTOR Inj Lös 12 mg/0.6ml Durchstf 7 Stk
Market launch
15/04/2009
Narcotic (BTM)
No

Other package sizes (1)

RELISTOR sol inj 12 mg/0.6ml flac
1 DUR
GTIN: 7680586520012
View